| PERIOD ENDING | 23-Oct-09 | 24-Jul-09 | 24-Apr-09 | 23-Jan-09 | | Total Revenue | 424,847 | 429,480 | 430,997 | 443,773 | | Cost of Revenue | (26,741) | 275,545 | (321,230) | 287,618 | | | Gross Profit | 451,588 | 153,935 | 752,227 | 156,155 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 406,003 | 107,813 | 700,284 | 113,951 | | Non Recurring |
-
|
-
|
-
| 67,962 | | Others | 20,678 | 20,983 | 20,944 | 20,676 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 24,907 | 25,139 | 30,999 | (46,434) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (133) | 133 | | Earnings Before Interest And Taxes | 19,630 | 25,139 | 30,866 | (46,301) | | Interest Expense | (2,740) | 2,740 | 2,658 | 3,329 | | Income Before Tax | 22,370 | 22,399 | 28,208 | (49,630) | | Income Tax Expense | 6,888 | 6,284 | 7,134 | 1,738 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 15,482 | 16,115 | 21,074 | (51,368) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 15,482 | 16,115 | 21,074 | (51,368) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $15,482 | $16,115 | $21,074 | ($51,368) |
|
0.31% Nasdaq 
0.05%
Income Statement
